Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, 243 Charles Street, Boston, MA 02114, USA.
J Assoc Res Otolaryngol. 2011 Apr;12(2):141-9. doi: 10.1007/s10162-010-0245-0. Epub 2010 Nov 4.
DFNA9 is an autosomal dominant cause of non-syndromic adult-onset sensorineural hearing loss with associated variable vestibular dysfunction caused by mutations in the COCH gene. DFNA9 has previously been characterized by the presence of unique histopathologic features limited to the cochlear and vestibular labyrinth. This report describes newly discovered extralabyrinthine findings within the middle ear in DFNA9 and discusses their implications. The histopathologic anatomy of extralabyrinthine structures was reviewed in 12 temporal bones from seven individuals with DFNA9 and compared with age-matched controls. All temporal bones with DFNA9 had abnormal deposits within the tympanic membrane, incudomalleal joint, and incudostapedial joint. Hematoxylin and eosin stain and Movat's pentachrome stain both revealed different staining patterns of the extralabyrinthine deposits compared with the intralabyrinthine deposits suggesting that the composition of the deposits varies with location. The deposits within the tympanic membrane resembled cartilage morphologically and stained positively for aggrecan, an extracellular matrix protein found in cartilage. However, the cellular component of the tympanic membrane deposits did not stain with immunomarkers for chondrocytes (s100 and connective tissue growth factor). These novel findings in DFNA9 have implications for the phenotypic expression of the disorder and the clinical workup of adult-onset sensorineural hearing loss.
DFNA9 是一种常染色体显性遗传疾病,可引起非综合征性成年起病的感觉神经性听力损失,并伴有前庭功能障碍,其病因是 COCH 基因突变。DFNA9 以前的特征是存在独特的组织病理学特征,仅限于耳蜗和前庭迷路。本报告描述了在 DFNA9 中发现的中耳内新的迷路外发现,并讨论了它们的意义。对 7 名 DFNA9 患者的 12 个颞骨中的迷路外结构的组织病理学解剖结构进行了回顾,并与年龄匹配的对照组进行了比较。所有患有 DFNA9 的颞骨都有鼓膜、砧镫关节和砧镫骨间关节的异常沉积。苏木精和伊红染色和 Movat 的五重染色均显示迷路外沉积物的染色模式与迷路内沉积物不同,表明沉积物的成分随位置而异。鼓膜内的沉积物在形态上类似于软骨,并且对聚集蛋白(一种存在于软骨中的细胞外基质蛋白)呈阳性染色。然而,鼓膜沉积物的细胞成分不能用软骨细胞的免疫标志物(s100 和结缔组织生长因子)染色。DFNA9 中的这些新发现对该疾病的表型表达和成年起病的感觉神经性听力损失的临床评估具有重要意义。